Axsome Therapeutics (AXSM) Interest & Investment Income (2022 - 2025)
Historic Interest & Investment Income for Axsome Therapeutics (AXSM) over the last 4 years, with Q3 2025 value amounting to -$1.1 million.
- Axsome Therapeutics' Interest & Investment Income rose 4337.71% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6 million, marking a year-over-year decrease of 5006.92%. This contributed to the annual value of -$6.6 million for FY2024, which is 179.76% down from last year.
- According to the latest figures from Q3 2025, Axsome Therapeutics' Interest & Investment Income is -$1.1 million, which was up 4337.71% from -$1.8 million recorded in Q2 2025.
- In the past 5 years, Axsome Therapeutics' Interest & Investment Income ranged from a high of -$702000.0 in Q4 2023 and a low of -$2.7 million during Q2 2023
- Over the past 4 years, Axsome Therapeutics' median Interest & Investment Income value was -$1.8 million (recorded in 2025), while the average stood at -$1.7 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first surged by 6860.22% in 2023, then tumbled by 21481.48% in 2024.
- Over the past 4 years, Axsome Therapeutics' Interest & Investment Income (Quarter) stood at -$1.3 million in 2022, then skyrocketed by 46.94% to -$702000.0 in 2023, then crashed by 214.81% to -$2.2 million in 2024, then soared by 49.32% to -$1.1 million in 2025.
- Its last three reported values are -$1.1 million in Q3 2025, -$1.8 million for Q2 2025, and -$2.4 million during Q1 2025.